Breast Cancer Screening
Breast cancer risk is strongly related to age, with more than 80% of cases occurring in women over 50 years old. The highest number of cases of breast cancer diagnosed is in the 50-64 age group, the age group targeted for screening.
Many of them are diagnosed as a result of the screening programme. Survival rates for breast cancer have increased, with 72% of women diagnosed with the disease now being likely to survive for 10 years. This is much improved on rates ten years ago when 64% of women would be expected to survive for 10 years.
The NHS Breast Screening Programme continues to work closely with units across the region to deliver breast screening for all women aged over 50.
Patients are targeted, through their GP surgery, on a three yearly rolling programme. This will therefore mean that you could be invited for screening at any point between the age of 50 and 53, depending on when our practice screening falls.
Bowel Cancer Screening
Approximately one in twenty people in the UK will develop bowel cancer during their lifetime. It is the third most common cancer in the UK, and the second leading cause of cancer deaths, with over 16,000 people dying from it each year. It affects men and women equally.
Regular bowel cancer screening has been shown to reduce the risk of dying from bowel cancer by 16%. From June 2008 a national bowel screening programme was introduced across Nottinghamshire County. This aims to detect bowel cancer at an early stage when treatment is more likely to be effective.
If you are aged 60-69 years old and registered at St. George's Medical Practice, you will automatically receive a free self-screening kit on a 2-yearly basis. You will be sent a simple test kit to complete in the privacy of your home. This will involve collecting a small sample from three separate bowel motions and, using a specially designed prepaid envelope, returning the kit to the laboratory for analysis.
Prostate Cancer Screening
Prostate cancer is a serious condition. The PSA test, which can give an early indication of prostate cancer, is available to you if you want to be tested. However, experts disagree on how useful the PSA test is. This is why there is a lot of research and why there is no national screening programme for prostate cancer in the UK. An information leaflet has been developed (see below) providing balanced information about the PSA test, which will hopefully help you to decide whether or not you wish to have the test.
PSA Test Information Leaflet